Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study
Clinical trial NCT02500511 · COMPLETED
Trial details
- NCT number
- NCT02500511
- Sponsor
- JN-International Medical Corporation
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-06-01
- Primary completion
- 2015-08-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.